Home

Brooks Laboratories Ltd EPS

Image

Brooks Laboratories Ltd

NSE: BROOKS

EPS

₹ -7.83

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Brooks Laboratories Ltd is ₹ -7.83 as of 21 Feb 25 .
  • The earning per share of Brooks Laboratories Ltd changed from ₹ -1.81 to ₹ -1.75 over 7 quarters. This represents a CAGR of -1.91% .

Historical Earning per Share of Brooks Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Brooks Laboratories Ltd

Market Cap

322 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

5.4

Day’s High

129.35

Day’s Low

122.05

DTE

0.2

ROE

-33.5

52 Week High

202.8

52 Week Low

72.51

ROCE

-27.5

Market Price of Brooks Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Brooks Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025122.8
20 Feb 2025123.25
19 Feb 2025123.5
18 Feb 2025118.85
17 Feb 2025124.05
14 Feb 2025134.55
13 Feb 2025142.95
12 Feb 2025136.15
11 Feb 2025142.6
10 Feb 2025155.8

SWOT Analysis Of Brooks Laboratories Ltd

Strength

1

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Brooks Laboratories Ltd

Asset Value vs Market Value of Brooks Laboratories Ltd

Market Value

322

Asset Value

Value addition

9.4 X

31

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Brooks Laboratories Ltd322.31
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Brooks Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Brooks Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Brooks Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Brooks Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Brooks Laboratories Ltd News Hub

Brooks Laboratories reports consolidated net loss of Rs 2.41 crore in the June 2024 quarter

Net Loss of Brooks Laboratories reported to Rs 2.41 crore in the quarter ended June 2024 as against

Read more

16 Aug 24

Brooks Laboratories schedules board meeting

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2024.

Read more

09 Aug 24

Brooks Laboratories to conduct AGM

Brooks Laboratories announced that the 22th Annual General Meeting (AGM) of the company will be held

Read more

03 Sept 24

Brooks Laboratories to hold AGM

Brooks Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 1

Read more

03 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Brooks Laboratories Ltd

What is the EPS of Brooks Laboratories Ltd stock?

The Earnings Per Share (EPS) of Brooks Laboratories Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Brooks Laboratories Ltd EPS calculated?

The EPS of Brooks Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Brooks Laboratories Ltd report its EPS?

Brooks Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Brooks Laboratories Ltd EPS?

Factors that influence the EPS of Brooks Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Brooks Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Brooks Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions